Psychiatrists should be talking to patients about sex: sexual dysfunction can exacerbate comorbid psychiatric disorders and contribute to medication nonadherence. psychiatrictimes.com/view/ad…
Ph2 findings for ALTO-203 showed improvements in attention, alertness, & EEG biomarkers in patients with depression. In a recent @PsychTimes interview, Amit Etkin, MD, PhD, discusses how these findings may help identify patients most likely to benefit.
bit.ly/444zSdI
🧠💊 This week's "Brain Trust" episode is now live!
Joseph Goldberg and guest Henry Nasrallah, discuss off-label prescribing and polypharmacy: psychiatrictimes.com/view/po…
Learn more about bretisilocin, a potential best-in-class compound for the treatment of major depressive disorder from @abbvie, and the evolving psychedelic landscape here: psychiatrictimes.com/view/de…
Social media disorder remains noticeably absent from psychiatric diagnostic frameworks. However, 83% of readers believe social media is addictive. What's the verdict?
Read our June cover story here: psychiatrictimes.com/view/en…
The June issue of Psychiatric Times is now live! This month, we examine the dangers of social media for our youth, highlighting the recent legal battles between teens and social media giants.
Download the issue now and follow along as articles are shared throughout the month.
📣 Mark your calendars!
The Jersey City Psychiatry Conference is October 2–3, 2026.
Two days of clinical education, emerging research, and real talk about where psychiatry is headed.
Early bird pricing is open now — but only through June 30. 🔗hubs.li/Q04kkZtS0
🎙️🧐💊 This week's "Brain Trust" episode is now live!
Joseph Goldberg and guest Robert M. Post, MD, discuss evolving perspectives on bipolar disorder and treatment, emphasizing early intervention and the underutilization of lithium: psychiatrictimes.com/view/po…
Phase 2 topline data show that elunetirom for the treatment of bipolar depression achieved statistical significance across the primary and all key secondary depression endpoints. psychiatrictimes.com/view/ne…
The FDA has issued a Complete Response Letter for CTx-1301, a novel formulation of dexmethylphenidate for treatment of ADHD. psychiatrictimes.com/view/fd…
This Memorial Day, Psychiatric Times honors the brave individuals who made the ultimate sacrifice in service to our country. We remember their courage, reflect on their legacy, and express gratitude to all who have served.
🎙️🧐💊 This week's "Brain Trust" episode is now live!
Guest Michael Gitlin, MD, shares insights on the complex psychopharmacology of personality disorders: psychiatrictimes.com/view/po…
Antipsychotic medications remain the most effective intervention for reducing psychotic symptoms and preventing relapse. Yet medication alone is often insufficient. Psychotherapy can play an important role in relapse prevention and long-term recovery. psychiatrictimes.com/view/ps…
The HHS has released the Surgeon General’s “Warning on the Harms of Screen Use," which aims to raise national awareness about the growing risks associated with excessive and harmful screen use among youth. psychiatrictimes.com/view/th…
The latest focus on psychedelic use for mood disorders and continued research into neuromodulation holds much potential. #APAAM26psychiatrictimes.com/shorts/…